Stereospecific Reduction of Keto Group in 3β-Triphenylmethoxy-5α-cholest-8(14)-en-15-one

The reduction of 3-triphenylmethoxy-5-cholest-8(14)-en-15-one with lithium aluminum hydride resulted in a quantitative yield of 3-triphenylmethoxy-5-cholest-8(14)-en-15-ol.     

Concerning the structure of 7α,15β-dichloro-5α-cholest-8(14)-en-3β-ol,a novel inhibitor of cholesterol biosynthesis

Treatment of 3β-p-bromobenzoyloxy-14α, 15α-epoxy-5α-cholest-7-ene with gaseous HCI in chloroform at ?25°C gave 3β-p-bromobenzoyloxy-7α, 15β-dichloro-5α-cholest-8(14)-ene in 93% yield. The structure of the latter compound was unequivocally established by the results of X-ray crystallographic analysis.     

Sterol synthesis. Synthesis of 15-oxygenated 5α, 14β-cholest-7-en-3β-ol derivatives

Treatment of 3β-benzoyloxy-14α, 15α-epoxy-5α-cholest-7-ene with boron trifluoride-etherate gave, in 43% yield, 3β-benzoyloxy-5α, 14β-cholest-7-en-15-one with the unnatural C ring juncture. Reduction of the latter compound with lithium aluminum hydride gave 15α, 14β-cholest-7-en-3β, 15α-diol and 5α, 14β-cholest-7-en-3β, 15β-diol in 9% and 81% yields, respectively.     

Chemical syntheses of 5α-cholesta-6,8(14)-dien-3β-ol-15-one and related 15-oxygenated sterols

Hydroboration of 5α-cholesta-8,14-dien-3β-ol (I) gave 5α-cholest-8-en-3β,15α-diol (IV) in 89% yield. 5α-Cholest-7-en-3β,15α-diol (V) was prepared in 91% yield by hydroboration of 5α-cholesta-7,14-dien-3β-ol (II). Hydroboration of 27:63 mixture of I and II gave IV and V in 18% and 70% yields, respectively. 5α-Cholest-8-en-15α-ol-3-one and 5α-cholest-7-en-15α-ol-3-one were prepared in high yields from IV and V, respectively, by either selective oxidation with silver carbonate-celite or by enzymatic oxidation using cholesterol oxidase. 7α,8α-Epoxy-5α-cholestan-3β,15α-diol (VIII) was prepared in 93% yield by treatment of V with m-chloroperbenzoic acid. 5α-Cholest-8(14)-en-7α-ol-3,15-dione (IX) was prepared in 56% yield by oxidation of VIII with pyridinium chlorochromate followed by treatment of the crude product with acid. Compound IX was also obtained in 72% yield by selective chemical oxidation of 5α-cholest-8(14)-en-3β,7α,15α-triol. 5α-Cholesta-6,8(14)-dien-3,15-dione (X) was prepared in 89% yield by treatment of IX with p-toluenesulfonic acid under controlled conditions. Reduction of X with lithium tri-tert-butoxyaluminum hydride under controlled conditions gave 5α-cholesta-6,8(14)-dien-3β-ol-15-one in 84% yield.     

Transformation of 3β-(2-Hydroxyethoxy)-5α-cholest-8(14)-en-15-one to a Polar Metabolite in Hepatoma Hep G2 Cells

Incubation of 3-(2-hydroxy-2[³H]-ethoxy)-5-cholest-8(14)-en-15-one with Hep G2 cells led to the accumulation of a radioactive polar product in the culture medium, which was identified as 3-(2-hydroxyethoxy)-15-keto-5-cholest-8(14)-ene-24-oic acid. Its structure was confirmed by a chemical counter synthesis. The labeled ketosterol was rapidly (t _1/2 = 6 min) and reversibly bound by Hep G2 cells. The intracellular concentration of 15-ketosterol decreased during incubation mainly due to the formation of a polar metabolite, secreted to the medium. The level of cholesterol biosynthesis was 22 ± 5% of the control value in Hep G2 cells at a 15-ketocholesterol concentration in the medium of 30 M. However, further incubation for 3 h in the medium without the ketosterol led to restoration of the level of biosynthesis to 85 ± 11% of the control value. These results suggest that inhibition of the cholesterol biosynthesis by 15-ketocholesterol in Hep G2 cells depends on the intracellular concentration of the inhibitor, which, in turn, is determined by the rate of its conversion into the polar metabolite.     

4α-Methyl-5α-cholest-8(14)-en-3β-ol from the seeds of Capsicum annuum

A 4α-methylsterol was isolated from the seeds of Capsicum annuum and was identified as 4α-methyl-5α-cholest-8(14)-en-3β-ol. This seems to b     

Stereoselectivity of raney nickel catalyst in hydrogenolysis of a steroidal α,β-unsaturated epoxide. Chemical synthesis of 3β-benzoyloxy-5α-cholest-8(14)-en-15α-ol

Hydrogenation of 3β-benzoyloxy-14α, 15α-epoxy-5α-cholest-7-ene in benzene over a Raney nickel catalyst gave 3β-benzoyloxy-5α-cholest-8(14)-en-15α-ol and 3β-benzoyloxy-5α-cholest-8(14)-ene in 39% and 46% yields, respectively. Hydrogenation of the same α,β-unsaturated epoxy steryl ester under the same conditions except with the inclusion of triethylamine (4%) gave 3β-benzoyloxy-5α-cholest-8(14)-en-15α-ol in 89% yield.     

Axillary 5α-androst-16-en-3-one,cholesterol and squalene in men; Preliminary evidence for 5α-androst-16-en-3-one being a product of bacterial action

Twenty-four hour axillary levels of the odorous steroid 5α-androst-16-en-3-one, have been measured in six men by radioimmunoassay. Initially, no control of bacterial activity was made and conditions attempting a normal axillary environment were maintained. The level of 5α-androst-16-en-3-one was significantly higher (P = 0.028) in one axilla (“superior”) than the other (“inferior”) and levels showed considerable variation both between and within individuals. This difference between axillae was also observed for cholesterol (P = 0.0013) but not for squalene (P = 0.18). This suggests that the presence of 5α-androst-16-en-3-one in the axilla does not correlate with sebum secretion. The effect of a general germicidal agent was tested by shaving and applying Povidone-iodine to the “superior” axilla whilst treating the “inferior” axilla as a control. A highly significant drop in the level of 5α-androst-16-en-one in the “superior” axilla below that in the control axilla was obtained (P = 0.000014, double tailed, as calculated using the Fisher Exact test). Squalene and cholesterol were measured in an attempt to monitor glandular activity and their levels were not significantly affected by Povidone-iodine. It is likely, therefore, that the production of 5α-androst-16-en-3-one is from metabolism of a precursor in the axillae by skin micro-organisms.     

Synthesis of (4-C)-labeled and non-labeled 3β,15α-dihydroxy-5-pregnen-20-one and 3β,15α-dihydroxy-5-androsten-17-one

The synthesis of labeled and non-labeled 3β,15α-dihydroxy-5-pregnen-20-one (V) and 3β, 15α-dihydroxy-5-androsten-17-one (XI) is described. Treatment of 15α-hydroxy-4-pregnene-3,20-dione (I) with acetic anhydride and acetyl chloride gave 3,15α-diacetoxy-3,5-pregnadien-20-one (II). The enol acetate (II) was ketalized by a modification of the general procedure to yield 3,15α-diacetoxy-3,5-pregnadien-20-one cyclic ethylene ketal (III) which was then reduced with NaBH₄ and LiAlH₄ to give 3β, 15α-dihydroxy-5-pregnen-20-one cyclic ethylene ketal (IV). Cleavage of the ketal group of IV gave V. Similarly, XI was prepared by starting with 15α-hydroxy-4-androstene-3,17-dione (VII). The (4-¹⁴C)-3β,15α-dihydroxy-5-pregnen-20-one was prepared by a modification of the above procedure in that the enol acetate (II)was directly reduced with NaBH₄ and LiAlH₄ to yield 5-pregnene-3β,15α,20β-triol (XIII) which was then oxidized enzymatically with 20β-hydroxysteroid dehydrogenase to V.     

Metabolism of 3β-hydroxy-5α- and 3β-hydroxy-5β-pregnan-20-one by leaf homogenates

Leaf homogenates of Cheiranthus cheiri, Nerium oleander, Strophanthus kombé, Digitalis purpurea, and Corchorus capsularis were ex     

Synthesis of 3β-hydroxy-androsta-5,7-dien-17-one from 3β-hydroxyandrost-5-en-17-one via microbial 7α-hydroxylation

The synthesis of 3β-hydroxy-androsta-5,7-dien-17-one from 3β-hydroxy-androst-5-en-17-one (dehydroepiandrosterone, DHEA) via microbial 7α-hydroxylation has been accomplished. At the first stage, 3β,7α-dihydroxy-androst-5-en-17-one was obtained in high yield (71.2%) using a strain of Gibberella zeae VKM F-2600, which was first applied for DHEA conversion. The further route included the substitution of 7α-hydroxyl group with chlorine followed by a dehydrochlorination stage, and required minimal purifications of the intermediate products. The steroids obtained at every step were characterized by TLC_,¹H NMR, MS, UV- and IR-spectrometry.The combination of microbial and chemical steps ensured 54.6% yield of the target 3β-hydroxy-androsta-5,7-dien-17-one from DHEA and can be applied for obtaining novel vitamin D derivatives.     

5α-Stigmast-9(11)-en-3β-ol,a sterol from Costus speciosus roots

A new sterol isolated from Costus species roots has been characterized as 5α-stigmast-9(11)-en-3β-ol by spectroscopic data and chemical studies.     

The crystal and molecular structure of d1-17β-hydroxy-8α-androst-4-en-3-one (8-isotestosterone)

The molecular conformation of d1-8-isotestosterone has been determined crystallographically. Crystals of the title compound belong to the space group P2₁/c with a = 11.449(4), b = 10.962(4), c = 25.860(5) , β = 100.95(4)⁰, with two molecules in the asymmetric unit. The structure has been refined to a final R value of 0.052 for 2227 reflections. Unlike testosterone, which is a flat molecule, its 8-isomer has a folded conformation. The conformations of the ring-B in the two crystallographically independent molecules (A and B) correspond to the twist form and differ significantly from one another.     

Evoked effects of oestradiol on hepatic cholesterol 7α-hydroxylase and drug oxidase in castrated rats

• 1.1. Oestradiol administration in castrated rats resulted in an increased activity of the cholesterolα-hydroxylase and a decreased activity of the drug oxidase enzyme systems.
• 2.2. Aqueous solutions of oestradiol (up to 25·10⁻⁶M) incubated in vitro with microsomes, binds into the microsomal membrane framework reducing the activity of both enzyme systems.
• 3.3. The specific activity of cholesterol 7α-hydroxylase. drops after 3 hr preincubation with oestradiol to at least 70% of its original value.
• 4.4. Actinomycin D and cycloheximide administration reduced the oestradiol-induced and control cholesterol 7α-hydroxylase activity to the same level, 6 hr after the injections.

     

Regulation of cholesterol biosynthesis and metabolism in Hep G2 cells by Δ8(14)-15-ketoergostane derivatives

The comparative study of effects of 5α-cholest-8(14)-en-15-on-3β-ol (I), (22E)-5α-ergosta-8(14),22-dien-15-on-3β-ol (II), (22S,23S)-22,23-oxido-5α-ergost-8(14)-en-15-on-3β-ol (III), and (22R,23R)-22,23-oxido-5α-ergost-8(14)-en-15-on-3β-ol (IV) on HMG-CoA reductase, CYP27A1 and CYP3A4 genes expression in Hep G2 cells was performed. In the contrast to the 15-ketocholestane derivative (I), 15-ketoergostane derivatives (II–IV) decreased the HMG-CoA reductase mRNA level; (22R, 23R)-22,23-oxido-5α-ergost-8(14)-en-15-on-3β-ol (IV) significantly increased CYP3A4 mRNA level (320% from control). Ketosterol (II) was found to be a more potent inhibitor of cholesterol biosynthesis in Hep G2 cells during prolonged incubation, compared with ketosterol (I). The side chain conformation of compounds (I)–(IV) was evaluated by computational modeling; the correlation between biological activity of these compounds and conformational flexibility of their side chains was found. The results obtained indicate that Δ8(14)-15-ketoergostane derivatives may be used as a sterol biosynthesis and metabolism regulators in liver cells.